Jpmorgan Chase & Co »

Phathom Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 146k 9.13
2023-09-30 $1.5M 145k 10.37
2023-06-30 $1.9M 134k 14.32
2023-03-31 $820k 115k 7.14
2022-12-31 $1.4M 129k 11.22
2022-06-30 $1.4M 171k 8.45
2022-03-31 $2.4M 176k 13.54
2021-12-31 $3.3M 173k 19.31
2021-03-31 $7.2M 194k 36.91
2020-12-31 $6.0M 187k 32.33
2020-09-30 $5.8M 163k 35.71
2020-06-30 $5.3M 160k 32.94
2020-03-31 $0 3.5k 0.00
2019-12-31 $109k 3.5k 31.06